Spiber Inc., a pioneering biotechnology company headquartered in Japan, is at the forefront of developing innovative materials derived from synthetic biology. Founded in 2007, Spiber has made significant strides in the field of bioengineered proteins, particularly in creating sustainable alternatives to traditional materials like silk and leather. With major operations in Japan and expanding global partnerships, Spiber focuses on producing its unique Brewed Protein™ materials, which are distinguished by their exceptional strength and versatility. The company has garnered attention for its commitment to sustainability and has collaborated with leading brands in the fashion and outdoor industries. Recognised for its groundbreaking advancements, Spiber is positioned as a leader in the biomaterials sector, driving the shift towards eco-friendly production methods and contributing to a more sustainable future.
How does Spiber's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Spiber's score of 28 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Spiber reported significant carbon emissions, with Scope 2 emissions totalling approximately 9,063,000 kg CO2e and Scope 3 emissions reaching about 290,611,000 kg CO2e. This data highlights the company's substantial indirect emissions, primarily from its supply chain and product use. In 2022, Spiber's total emissions were approximately 2,529,000 kg CO2e, which included Scope 1 emissions of about 1,881,000 kg CO2e and Scope 2 emissions of around 3,720,000 kg CO2e. The combined Scope 1 and 2 emissions for that year were approximately 5,010,000 kg CO2e. Despite the detailed emissions reporting, Spiber has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company does not appear to inherit emissions data from a parent organisation, as it operates independently. Overall, Spiber's emissions profile underscores the importance of addressing both direct and indirect emissions in its climate strategy, particularly as it navigates the challenges of sustainability in the biotechnology sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 1,881,000 | - |
| Scope 2 | 3,720,000 | 0,000,000 |
| Scope 3 | - | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Spiber has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

